Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Equity Group A/S - Annual Report 2025
Pharma Equity Group A/S - Annual Report 2025 Pharma Equity Group A/S - Annual Report 2025 – Highlights of the year Today, the Board of Directors of Pharma Equity Group A/S reviewed and approved the Company's Annual Report for 2025, the key…
Notice convening the annual general meeting in Pharma Equity Group A/S
Notice convening the annual general meeting in Pharma Equity Group A/S The board of directors hereby convenes the annual general meeting in Pharma Equity Group A/S (“PEG” or the “Company”) to be held on: The agenda for…
Bain-Owned Tanabe Pharma Targets Global Deals To Fuel Growth
Bain Capital -owned Tanabe Pharma Corp. is on the hunt for licensing deals abroad to bring medicines into Japan, betting that unmet patient demand and easing regulations will fuel growth. A new team of around eight people is sourcing therapies in…
Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Morpeth recently commissioned a new Korsch XM12 Single Layer/Bilayer press, a smaller-scale model that laid the foundation for the site's commitment to the latest tablet press technology in the PreCommercial domain. As late phase and commercial…
Alumis: Oral Psoriasis Med Can Win Approval, Challenge Big Pharma In Major Markets (ALMS)
Alumis Inc. is upgraded to Buy, reversing a prior Sell, based on strong Phase 3 envudeucitinib psoriasis data and pipeline potential. Envudeucitinib demonstrated efficacy comparable to JNJ's newly approved Icotyde, with 74% PASI 75 and 59% sPGA 0/1…
Aurobindo Pharma arm ties up with European firm for biosimilars
Aurobindo Pharma subsidiary CuraTeQ Biologics has entered into a marketing and distribution agreement with European healthcare and pharmaceuticals company STADA Arzneimittel AG for two biosimilars. Under the agreement, STADA will market and…
FBI's 'Operation Box Cutter' indicts Chinese pharma firms, terror-linked cartel assets in fentanyl takedown
EXCLUSIVE: Six Chinese citizens and two China-based pharmaceutical companies have been indicted for allegedly selling and delivering chemical precursors used to make fentanyl intended to be smuggled into the United States, as well as forging an…
UK-Swiss trade deal held up over pharma row
At the center of the disagreement is something called a Supplementary Protection Certificate (SPC). The U.K., Switzerland and the EU all operate SPC regimes, which extend patent protection for pharmaceuticals beyond the standard 20-year term. Swiss…
Earnings Scheduled For March 25, 2026 - ATA Creativity Global (NASDAQ:AACG), Ascentage Pharma Group (NASDAQ:AAPG)
• Chewy (NYSE:) is expected to report quarterly earnings at $0.20 per share on revenue of $3.26 billion. • Maze Therapeutics (NASDAQ:) is estimated to report earnings for its fourth quarter. • Winnebago Industries (NYSE:) is…
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of 'Hold' by Analysts
aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) has been given a consensus recommendation of 'Hold' by the seven research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a…
Spyglass Pharma (NASDAQ:SGP) Stock Price Down 10.1% - Time to Sell?
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) fell 10.1% during trading on Tuesday. The stock traded as low as $24.31 and last traded at $23.68. 28,945 shares changed hands during trading, a decline of 78% from the average session volume of…
Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025
Intended audience: global business, financial and trade media HERNEXEOS (zongertinib) and JASCAYD (nerandomilast) launched in H2, 2025 Group net sales increased 7.3%* to EUR 27.8 billion in 2025 R&D investments grew to EUR 6.4 billion, equivalent…
Short Interest in Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Increases By 546.9%
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling 951 shares, an increase…
Paysign (PAYS) Q4 2025 Earnings Call Transcript
Tuesday, March 24, 2026 at 5 p.m. ET President & Chief Executive Officer — Mark Newcomer Chief Financial Officer — Jeffery Baker President, Patient Affordability — Matthew Turner Chief Payments Officer — Matt Lanford…
Why Dr Reddy's generic weight-loss drug under Olymviq brand won't hit markets till Friday
4 min read New Delhi Make us preferred source on Google Several cheaper generics of semaglutide, the blockbuster weight-loss drug, launched in India this week, though Dr Reddy's Laboratories' (DRL) generic version, under the Olymviq brand, will not…
Receive a Daily briefing on Pharma Industry News
Get Started